Patrick Machado, 10% Owner at Urovant Sciences Ltd. (UROV), bought 24,697 shares at $7.97 ($194K) on 2019-05-30, disclosed to the SEC on 2019-06-03.
Open-market purchase of $194k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 6,951 | $55K | 28.5% |
| 2 | $7.97 | 6,951 | $55K | 28.5% |
| 3 | $8.91 | 300 | $3K | 1.4% |
| 4 | $7.70 | 5,071 | $39K | 20.1% |
| 5 | $7.71 | 5,424 | $42K | 21.5% |
| Total | $7.87 avg | 24,697 |
| $194K |
| 100% |
| Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |